S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
Log in

Kadmon Stock Price, News & Analysis (NYSE:KDMN)

$2.81
+0.10 (+3.69 %)
(As of 10/17/2019 04:00 PM ET)
Today's Range
$2.74
Now: $2.81
$2.82
50-Day Range
$2.06
MA: $2.58
$2.81
52-Week Range
$1.63
Now: $2.81
$3.08
Volume155,319 shs
Average Volume833,085 shs
Market Capitalization$364.27 million
P/E RatioN/A
Dividend YieldN/A
Beta2.19
Kadmon Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. The company markets and distributes products in various therapeutic areas, including ribavirin products for chronic hepatitis C virus infection; and distributes products in various therapeutic areas, including tetrabenazine for the treatment of chorea associated with Huntington's disease. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone212-308-6000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.40 million
Book Value$0.41 per share

Profitability

Net Income$-54,250,000.00
Net Margins-3,974.23%

Miscellaneous

Employees116
Market Cap$364.27 million
Next Earnings Date11/8/2019 (Estimated)
OptionableOptionable

Receive KDMN News and Ratings via Email

Sign-up to receive the latest news and ratings for KDMN and its competitors with MarketBeat's FREE daily newsletter.


Kadmon (NYSE:KDMN) Frequently Asked Questions

What is Kadmon's stock symbol?

Kadmon trades on the New York Stock Exchange (NYSE) under the ticker symbol "KDMN."

How were Kadmon's earnings last quarter?

Kadmon Holdings Inc (NYSE:KDMN) issued its earnings results on Monday, August, 5th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.16) by $0.03. The company had revenue of $0.23 million for the quarter, compared to the consensus estimate of $0.46 million. Kadmon had a negative return on equity of 96.96% and a negative net margin of 3,974.23%. View Kadmon's Earnings History.

When is Kadmon's next earnings date?

Kadmon is scheduled to release their next quarterly earnings announcement on Friday, November 8th 2019. View Earnings Estimates for Kadmon.

What price target have analysts set for KDMN?

5 brokerages have issued 1 year target prices for Kadmon's stock. Their predictions range from $2.77 to $25.00. On average, they expect Kadmon's stock price to reach $8.93 in the next twelve months. This suggests a possible upside of 217.9% from the stock's current price. View Analyst Price Targets for Kadmon.

What is the consensus analysts' recommendation for Kadmon?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kadmon in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Kadmon.

Has Kadmon been receiving favorable news coverage?

News stories about KDMN stock have trended somewhat negative recently, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Kadmon earned a media sentiment score of -1.4 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Kadmon.

Who are some of Kadmon's key competitors?

What other stocks do shareholders of Kadmon own?

Who are Kadmon's key executives?

Kadmon's management team includes the folowing people:
  • Dr. Harlan W. Waksal, Pres, CEO & Director (Age 66)
  • Mr. Steven Meehan, Exec. VP & CFO (Age 54)
  • Mr. Steven N. Gordon, Chief Admin., Compliance & Legal Officer, Exec. VP & Gen. Counsel (Age 51)
  • Ms. Cynthia L. Schwalm, Director (Age 59)
  • Mr. Kyle Carver, Controller & Principal Accounting Officer

When did Kadmon IPO?

(KDMN) raised $101 million in an IPO on Wednesday, July 27th 2016. The company issued 5,600,000 shares at a price of $16.00-$20.00 per share. Citigroup and Jefferies acted as the underwriters for the IPO and JMP Securities and H.C. Wainwright & Co. were co-managers.

Who are Kadmon's major shareholders?

Kadmon's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Meeder Asset Management Inc. (0.01%). View Institutional Ownership Trends for Kadmon.

Which institutional investors are buying Kadmon stock?

KDMN stock was purchased by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc.. View Insider Buying and Selling for Kadmon.

How do I buy shares of Kadmon?

Shares of KDMN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Kadmon's stock price today?

One share of KDMN stock can currently be purchased for approximately $2.81.

How big of a company is Kadmon?

Kadmon has a market capitalization of $364.27 million and generates $1.40 million in revenue each year. The company earns $-54,250,000.00 in net income (profit) each year or ($1.03) on an earnings per share basis. Kadmon employs 116 workers across the globe.View Additional Information About Kadmon.

What is Kadmon's official website?

The official website for Kadmon is http://www.kadmon.com/.

How can I contact Kadmon?

Kadmon's mailing address is 450 East 29th Street, New York NY, 10016. The company can be reached via phone at 212-308-6000 or via email at [email protected]


MarketBeat Community Rating for Kadmon (NYSE KDMN)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  226 (Vote Outperform)
Underperform Votes:  199 (Vote Underperform)
Total Votes:  425
MarketBeat's community ratings are surveys of what our community members think about Kadmon and other stocks. Vote "Outperform" if you believe KDMN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KDMN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Featured Article: What is Cost of Capital?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel